Webinars
January 19, 2023
New Frontiers for Neurology Laboratory Medicine
Ultrasensitive immunoassays have launched an explosion of research on blood biomarkers for a variety of...
December 14, 2022
Exploring the Role of IFNa in Autoimmunity and Infection
Abstract: Type I interferons (IFNs) are essential mediators of antiviral responses. These cytokines...
August 25, 2022
Ultra-Sensitive IL-11 Target Engagement Assay Development
Interleukin-11 (IL-11) is an interesting and unique pleiotropic cytokine, originally characterized as a...
June 21, 2022
Detecting Alzheimer’s Disease Pathology in Blood
Exploring applications for therapeutic trials and clinical use The development of blood biomarkers...
May 11, 2022
Employing Serum NfL Measurements for Management of Multiple Sclerosis
Multiple sclerosis (MS) affects close to 3 million people worldwide, and incidence rates have risen over the...
April 11, 2022
Post-AD/PD 2022 Webinar and Q&A: Simoa® highlights
Our Field Applications Scientist Danilo La Terra recently presented some of the Simoa® highlights from...
September 9, 2021
Cytokine Profiles and Personalized Therapeutics in COVID-19 Patients
Recent observations by Prof. Gorochov’s team at the CIMI Research Centre suggest that there are at least...
April 23, 2021
at 10:00 am EDT
Recent Advancements in Neurodegenerative Biomarkers: Progress Towards a Diagnostic Blood Test for Alzheimer’s Disease
With much enthusiasm following the research coming out of AD/PD™2021, we are pleased to bring together...
November 19, 2020
Simoa Success Webinar: Custom Assay Development Focus
November 19, 2020 Learn more about groundbreaking Simoa technology! Simoa Success Seminars have...